Phenotypic Analysis of Mice Expressing Exclusively Apolipoprotein B48 or Apolipoprotein B100

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1996 Jun 25

PMID 8692825

Citations 52

Authors

R V Farese Jr

M M Veniant

C M Cham

L M Flynn

V Pierotti

J F Loring

M Traber

S Ruland

R S Stokowski

D Huszar

S G Young

Affiliations

Soon will be listed here.

Abstract

Apolipoprotein (apo)-B is found in two forms in mammals: apo-B100, which is made in the liver and the yolk sac, and apo-B48, a truncated protein made in the intestine. To provide models for understanding the physiologic purpose for the two forms of apo-B, we used targeted mutagenesis of the apo-B gene to generate mice that synthesize exclusively apo-B48 (apo-B48-only mice) and mice that synthesize exclusively apo-B100 (apo-B100-only mice). Both the apo-B48-only mice and apo-B100-only mice developed normally, were healthy, and were fertile. Thus, apo-B48 synthesis was sufficient for normal embryonic development, and the synthesis of apo-B100 in the intestines of adult mice caused no readily apparent adverse effects on intestinal function or nutrition. Compared with wild-type mice fed a chow diet, the levels of low density lipoprotein (LDL)-cholesterol and very low density lipoprotein- and LDL-triacylglycerols were lower in apo-B48-only mice and higher in the apo-B100-only mice. In the setting of apo-E-deficiency, the apo-B100-only mutation lowered cholesterol levels, consistent with the fact that apo-B100-lipoproteins can be cleared from the plasma via the LDL receptor, whereas apo-B48-lipoproteins lacking apo-E cannot. The apo-B48-only and apo-B100-only mice should prove to be valuable models for experiments designed to understand the purpose for the two forms of apo-B in mammalian metabolism.

Citing Articles

Translatome profiling reveals Itih4 as a novel smooth muscle cell-specific gene in atherosclerosis.

Ravindran A, Holappa L, Niskanen H, Skovorodkin I, Kaisto S, Beter M Cardiovasc Res. 2024; 120(8):869-882.

PMID: 38289873 PMC: 11218691. DOI: 10.1093/cvr/cvae028.

Dissecting the polygenic basis of atherosclerosis via disease-associated cell state signatures.

Ord T, Lonnberg T, Nurminen V, Ravindran A, Niskanen H, Kiema M Am J Hum Genet. 2023; 110(5):722-740.

PMID: 37060905 PMC: 10183377. DOI: 10.1016/j.ajhg.2023.03.013.

Potential therapeutic targets for age-related macular degeneration: The nuclear option.

Choudhary M, Malek G Prog Retin Eye Res. 2022; 94:101130.

PMID: 36220751 PMC: 10082136. DOI: 10.1016/j.preteyeres.2022.101130.

Development and validation of a method to deliver vitamin A to macrophages.

Acharya P, Black M, Bressner G, Amengual J Methods Enzymol. 2022; 674:363-389.

PMID: 36008013 PMC: 9661891. DOI: 10.1016/bs.mie.2022.04.008.

Characterization and identification of measurable endpoints in a mouse model featuring age-related retinal pathologies: a platform to test therapies.

Choudhary M, Tayyari F, Handa J, Malek G Lab Invest. 2022; 102(10):1132-1142.

PMID: 35589984 PMC: 10041606. DOI: 10.1038/s41374-022-00795-7.

References

Milne R, Weech P, Blanchette L, Davignon J, Alaupovic P, Marcel Y . Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest. 1984; 73(3):816-23. PMC: 425085. DOI: 10.1172/JCI111276. View

Farese Jr R, Cases S, Ruland S, KAYDEN H, Wong J, Young S . A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J Lipid Res. 1996; 37(2):347-60. View

Young S, Bertics S, Scott T, Dubois B, Curtiss L, Witztum J . Parallel expression of the MB19 genetic polymorphism in apoprotein B-100 and apoprotein B-48. Evidence that both apoproteins are products of the same gene. J Biol Chem. 1986; 261(7):2995-8. View

Lang J, Gohil K, Packer L . Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem. 1986; 157(1):106-16. DOI: 10.1016/0003-2697(86)90203-4. View

McMahon A, Bradley A . The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell. 1990; 62(6):1073-85. DOI: 10.1016/0092-8674(90)90385-r. View

Young S . Recent progress in understanding apolipoprotein B. Circulation. 1990; 82(5):1574-94. DOI: 10.1161/01.cir.82.5.1574. View

Valancius V, SMITHIES O . Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol Cell Biol. 1991; 11(3):1402-8. PMC: 369413. DOI: 10.1128/mcb.11.3.1402-1408.1991. View

Hasty P, Ramirez-Solis R, Krumlauf R, Bradley A . Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature. 1991; 350(6315):243-6. DOI: 10.1038/350243a0. View

Yao Z, Blackhart B, Johnson D, Taylor S, Haubold K, McCarthy B . Elimination of apolipoprotein B48 formation in rat hepatoma cell lines transfected with mutant human apolipoprotein B cDNA constructs. J Biol Chem. 1992; 267(2):1175-82. View

10.

Shimano H, Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K . Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc Natl Acad Sci U S A. 1992; 89(5):1750-4. PMC: 48530. DOI: 10.1073/pnas.89.5.1750. View

11.

Piedrahita J, Zhang S, Hagaman J, Oliver P, Maeda N . Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992; 89(10):4471-5. PMC: 49104. DOI: 10.1073/pnas.89.10.4471. View

12.

Homanics G, Smith T, Zhang S, Lee D, Young S, Maeda N . Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc Natl Acad Sci U S A. 1993; 90(6):2389-93. PMC: 46092. DOI: 10.1073/pnas.90.6.2389. View

13.

Linton M, Farese Jr R, Young S . Familial hypobetalipoproteinemia. J Lipid Res. 1993; 34(4):521-41. View

14.

Greeve J, Altkemper I, Dieterich J, Greten H, Windler E . Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res. 1993; 34(8):1367-83. View

15.

Linton M, Farese Jr R, Chiesa G, Grass D, Chin P, Hammer R . Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest. 1993; 92(6):3029-37. PMC: 288508. DOI: 10.1172/JCI116927. View

16.

Rudolph U, Brabet P, Hasty P, Bradley A, Birnbaumer L . Disruption of the G(i2) alpha locus in embryonic stem cells and mice: a modified hit and run strategy with detection by a PCR dependent on gap repair. Transgenic Res. 1993; 2(6):345-55. DOI: 10.1007/BF01976176. View

17.

Teng B, Blumenthal S, Forte T, Navaratnam N, Scott J, Gotto Jr A . Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem. 1994; 269(47):29395-404. View

18.

Farese Jr R, Ruland S, Flynn L, Stokowski R, Young S . Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc Natl Acad Sci U S A. 1995; 92(5):1774-8. PMC: 42602. DOI: 10.1073/pnas.92.5.1774. View

19.

Zeiher B, Eichwald E, Zabner J, Smith J, Puga A, McCray Jr P . A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest. 1995; 96(4):2051-64. PMC: 185844. DOI: 10.1172/JCI118253. View

20.

Hirano K, Young S, Farese Jr R, Ng J, Sande E, Warburton C . Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem. 1996; 271(17):9887-90. DOI: 10.1074/jbc.271.17.9887. View